nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—CYP2C19—Methazolamide—glaucoma	0.0855	0.142	CbGbCtD
Norethindrone—CYP3A5—Clonidine—glaucoma	0.0767	0.127	CbGbCtD
Norethindrone—CYP2C19—Timolol—glaucoma	0.0727	0.121	CbGbCtD
Norethindrone—CYP3A4—Pilocarpine—glaucoma	0.0612	0.101	CbGbCtD
Norethindrone—ABCB1—Timolol—glaucoma	0.0587	0.0972	CbGbCtD
Norethindrone—ABCB1—Clonidine—glaucoma	0.0499	0.0827	CbGbCtD
Norethindrone—CYP3A4—Brinzolamide—glaucoma	0.048	0.0796	CbGbCtD
Norethindrone—CYP3A4—Dorzolamide—glaucoma	0.0464	0.0769	CbGbCtD
Norethindrone—CYP3A4—Methazolamide—glaucoma	0.0414	0.0685	CbGbCtD
Norethindrone—CYP3A4—Acetazolamide—glaucoma	0.0331	0.0548	CbGbCtD
Norethindrone—CYP3A4—Clonidine—glaucoma	0.0299	0.0495	CbGbCtD
Norethindrone—Cortisone acetate—NR3C1—glaucoma	0.00129	0.255	CrCbGaD
Norethindrone—Weight increased—Clonidine—glaucoma	0.000912	0.00238	CcSEcCtD
Norethindrone—Tension—Dorzolamide—glaucoma	0.000909	0.00237	CcSEcCtD
Norethindrone—Nervousness—Dorzolamide—glaucoma	0.000899	0.00235	CcSEcCtD
Norethindrone—Flatulence—Brinzolamide—glaucoma	0.000897	0.00234	CcSEcCtD
Norethindrone—Rash—Metipranolol—glaucoma	0.000895	0.00234	CcSEcCtD
Norethindrone—Skin disorder—Apraclonidine—glaucoma	0.000895	0.00234	CcSEcCtD
Norethindrone—Dermatitis—Metipranolol—glaucoma	0.000895	0.00233	CcSEcCtD
Norethindrone—Drowsiness—Clonidine—glaucoma	0.000894	0.00233	CcSEcCtD
Norethindrone—Tension—Brinzolamide—glaucoma	0.000893	0.00233	CcSEcCtD
Norethindrone—Asthenia—Levobunolol—glaucoma	0.000892	0.00233	CcSEcCtD
Norethindrone—Depression—Clonidine—glaucoma	0.000891	0.00233	CcSEcCtD
Norethindrone—Headache—Metipranolol—glaucoma	0.00089	0.00232	CcSEcCtD
Norethindrone—Alopecia—Pilocarpine—glaucoma	0.000888	0.00232	CcSEcCtD
Norethindrone—Nervousness—Brinzolamide—glaucoma	0.000884	0.00231	CcSEcCtD
Norethindrone—Pruritus—Levobunolol—glaucoma	0.000879	0.00229	CcSEcCtD
Norethindrone—Convulsion—Acetazolamide—glaucoma	0.000875	0.00228	CcSEcCtD
Norethindrone—Dizziness—Carteolol—glaucoma	0.00087	0.00227	CcSEcCtD
Norethindrone—Skin disorder—Bimatoprost—glaucoma	0.000868	0.00226	CcSEcCtD
Norethindrone—Flatulence—Pilocarpine—glaucoma	0.000862	0.00225	CcSEcCtD
Norethindrone—Tension—Pilocarpine—glaucoma	0.000858	0.00224	CcSEcCtD
Norethindrone—Dizziness—Diclofenamide—glaucoma	0.000855	0.00223	CcSEcCtD
Norethindrone—Asthenia—Methazolamide—glaucoma	0.000854	0.00223	CcSEcCtD
Norethindrone—Nervousness—Pilocarpine—glaucoma	0.00085	0.00222	CcSEcCtD
Norethindrone—Nausea—Metipranolol—glaucoma	0.000843	0.0022	CcSEcCtD
Norethindrone—Fluoxymesterone—NR3C1—glaucoma	0.000841	0.167	CrCbGaD
Norethindrone—Dizziness—Carbachol—glaucoma	0.000835	0.00218	CcSEcCtD
Norethindrone—Insomnia—Apraclonidine—glaucoma	0.000834	0.00217	CcSEcCtD
Norethindrone—Pain in extremity—Timolol—glaucoma	0.000825	0.00215	CcSEcCtD
Norethindrone—Anaphylactic shock—Acetazolamide—glaucoma	0.000824	0.00215	CcSEcCtD
Norethindrone—Headache—Carteolol—glaucoma	0.000824	0.00215	CcSEcCtD
Norethindrone—Vomiting—Diclofenamide—glaucoma	0.000822	0.00215	CcSEcCtD
Norethindrone—Dizziness—Levobunolol—glaucoma	0.000822	0.00215	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00082	0.00214	CcSEcCtD
Norethindrone—Somnolence—Apraclonidine—glaucoma	0.000819	0.00214	CcSEcCtD
Norethindrone—Pruritus—Latanoprost—glaucoma	0.000816	0.00213	CcSEcCtD
Norethindrone—Rash—Diclofenamide—glaucoma	0.000815	0.00213	CcSEcCtD
Norethindrone—Affect lability—Timolol—glaucoma	0.000812	0.00212	CcSEcCtD
Norethindrone—Headache—Diclofenamide—glaucoma	0.00081	0.00211	CcSEcCtD
Norethindrone—Insomnia—Bimatoprost—glaucoma	0.000808	0.00211	CcSEcCtD
Norethindrone—Vomiting—Carbachol—glaucoma	0.000803	0.00209	CcSEcCtD
Norethindrone—Hepatitis—Clonidine—glaucoma	0.000803	0.00209	CcSEcCtD
Norethindrone—Rash—Carbachol—glaucoma	0.000796	0.00208	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000796	0.00208	CcSEcCtD
Norethindrone—Dermatitis—Carbachol—glaucoma	0.000795	0.00208	CcSEcCtD
Norethindrone—Fatigue—Apraclonidine—glaucoma	0.000795	0.00207	CcSEcCtD
Norethindrone—Weight increased—Betaxolol—glaucoma	0.000794	0.00207	CcSEcCtD
Norethindrone—Somnolence—Bimatoprost—glaucoma	0.000794	0.00207	CcSEcCtD
Norethindrone—Oedema—Brimonidine—glaucoma	0.000791	0.00206	CcSEcCtD
Norethindrone—Headache—Carbachol—glaucoma	0.000791	0.00206	CcSEcCtD
Norethindrone—Dyspepsia—Bimatoprost—glaucoma	0.000787	0.00205	CcSEcCtD
Norethindrone—Mood swings—Timolol—glaucoma	0.000782	0.00204	CcSEcCtD
Norethindrone—Nausea—Carteolol—glaucoma	0.000781	0.00204	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000779	0.00203	CcSEcCtD
Norethindrone—Headache—Levobunolol—glaucoma	0.000779	0.00203	CcSEcCtD
Norethindrone—Depression—Betaxolol—glaucoma	0.000776	0.00203	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000771	0.00201	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00077	0.00201	CcSEcCtD
Norethindrone—Skin disorder—Brimonidine—glaucoma	0.000769	0.00201	CcSEcCtD
Norethindrone—Nausea—Diclofenamide—glaucoma	0.000768	0.002	CcSEcCtD
Norethindrone—Acute coronary syndrome—Betaxolol—glaucoma	0.000767	0.002	CcSEcCtD
Norethindrone—Myocardial infarction—Betaxolol—glaucoma	0.000763	0.00199	CcSEcCtD
Norethindrone—Dizziness—Latanoprost—glaucoma	0.000762	0.00199	CcSEcCtD
Norethindrone—Vomiting—Methazolamide—glaucoma	0.000757	0.00198	CcSEcCtD
Norethindrone—Oedema—Dorzolamide—glaucoma	0.000756	0.00197	CcSEcCtD
Norethindrone—Anaphylactic shock—Dorzolamide—glaucoma	0.000756	0.00197	CcSEcCtD
Norethindrone—Gastrointestinal pain—Apraclonidine—glaucoma	0.000754	0.00197	CcSEcCtD
Norethindrone—Oedema—Travoprost—glaucoma	0.000752	0.00196	CcSEcCtD
Norethindrone—Rash—Methazolamide—glaucoma	0.000751	0.00196	CcSEcCtD
Norethindrone—Dermatitis—Methazolamide—glaucoma	0.00075	0.00196	CcSEcCtD
Norethindrone—Nausea—Carbachol—glaucoma	0.00075	0.00196	CcSEcCtD
Norethindrone—Headache—Methazolamide—glaucoma	0.000746	0.00195	CcSEcCtD
Norethindrone—Breast disorder—Timolol—glaucoma	0.000746	0.00195	CcSEcCtD
Norethindrone—Nausea—Levobunolol—glaucoma	0.000738	0.00193	CcSEcCtD
Norethindrone—Somnolence—Acetazolamide—glaucoma	0.000733	0.00191	CcSEcCtD
Norethindrone—Skin disorder—Travoprost—glaucoma	0.000731	0.00191	CcSEcCtD
Norethindrone—Abdominal pain—Apraclonidine—glaucoma	0.000729	0.0019	CcSEcCtD
Norethindrone—Rash—Latanoprost—glaucoma	0.000727	0.0019	CcSEcCtD
Norethindrone—Dermatitis—Latanoprost—glaucoma	0.000726	0.00189	CcSEcCtD
Norethindrone—Dyspepsia—Acetazolamide—glaucoma	0.000726	0.00189	CcSEcCtD
Norethindrone—Headache—Latanoprost—glaucoma	0.000722	0.00188	CcSEcCtD
Norethindrone—Skin disorder—Brinzolamide—glaucoma	0.000722	0.00188	CcSEcCtD
Norethindrone—Insomnia—Brimonidine—glaucoma	0.000716	0.00187	CcSEcCtD
Norethindrone—Oedema—Pilocarpine—glaucoma	0.000714	0.00186	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000712	0.00186	CcSEcCtD
Norethindrone—Fatigue—Acetazolamide—glaucoma	0.000711	0.00185	CcSEcCtD
Norethindrone—Alopecia—Clonidine—glaucoma	0.000709	0.00185	CcSEcCtD
Norethindrone—Nausea—Methazolamide—glaucoma	0.000707	0.00185	CcSEcCtD
Norethindrone—Somnolence—Brimonidine—glaucoma	0.000703	0.00184	CcSEcCtD
Norethindrone—Mental disorder—Clonidine—glaucoma	0.000703	0.00183	CcSEcCtD
Norethindrone—Progesterone—CYP1B1—glaucoma	0.000701	0.139	CrCbGaD
Norethindrone—Dyspepsia—Brimonidine—glaucoma	0.000696	0.00182	CcSEcCtD
Norethindrone—Tension—Clonidine—glaucoma	0.000686	0.00179	CcSEcCtD
Norethindrone—Insomnia—Dorzolamide—glaucoma	0.000683	0.00178	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000683	0.00178	CcSEcCtD
Norethindrone—Fatigue—Brimonidine—glaucoma	0.000682	0.00178	CcSEcCtD
Norethindrone—Hypersensitivity—Apraclonidine—glaucoma	0.000679	0.00177	CcSEcCtD
Norethindrone—Nervousness—Clonidine—glaucoma	0.000679	0.00177	CcSEcCtD
Norethindrone—Insomnia—Brinzolamide—glaucoma	0.000672	0.00175	CcSEcCtD
Norethindrone—Somnolence—Dorzolamide—glaucoma	0.000672	0.00175	CcSEcCtD
Norethindrone—Dyspepsia—Dorzolamide—glaucoma	0.000665	0.00174	CcSEcCtD
Norethindrone—Testosterone—CYP1B1—glaucoma	0.000663	0.132	CrCbGaD
Norethindrone—Dyspepsia—Travoprost—glaucoma	0.000662	0.00173	CcSEcCtD
Norethindrone—Asthenia—Apraclonidine—glaucoma	0.000661	0.00173	CcSEcCtD
Norethindrone—Somnolence—Brinzolamide—glaucoma	0.00066	0.00172	CcSEcCtD
Norethindrone—Urticaria—Acetazolamide—glaucoma	0.000655	0.00171	CcSEcCtD
Norethindrone—Dyspepsia—Brinzolamide—glaucoma	0.000654	0.00171	CcSEcCtD
Norethindrone—Pruritus—Apraclonidine—glaucoma	0.000652	0.0017	CcSEcCtD
Norethindrone—Fatigue—Dorzolamide—glaucoma	0.000651	0.0017	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Travoprost—glaucoma	0.00065	0.00169	CcSEcCtD
Norethindrone—Fatigue—Travoprost—glaucoma	0.000649	0.00169	CcSEcCtD
Norethindrone—Insomnia—Pilocarpine—glaucoma	0.000646	0.00169	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000641	0.00167	CcSEcCtD
Norethindrone—Asthenia—Bimatoprost—glaucoma	0.000641	0.00167	CcSEcCtD
Norethindrone—Fatigue—Brinzolamide—glaucoma	0.00064	0.00167	CcSEcCtD
Norethindrone—Somnolence—Pilocarpine—glaucoma	0.000635	0.00166	CcSEcCtD
Norethindrone—Depression—Timolol—glaucoma	0.000634	0.00165	CcSEcCtD
Norethindrone—Pruritus—Bimatoprost—glaucoma	0.000632	0.00165	CcSEcCtD
Norethindrone—Immune system disorder—Betaxolol—glaucoma	0.000631	0.00165	CcSEcCtD
Norethindrone—Dyspepsia—Pilocarpine—glaucoma	0.000628	0.00164	CcSEcCtD
Norethindrone—Gastrointestinal pain—Dorzolamide—glaucoma	0.000618	0.00161	CcSEcCtD
Norethindrone—Alopecia—Betaxolol—glaucoma	0.000617	0.00161	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000616	0.00161	CcSEcCtD
Norethindrone—Gastrointestinal pain—Travoprost—glaucoma	0.000615	0.00161	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—glaucoma	0.000614	0.122	CrCbGaD
Norethindrone—Mental disorder—Betaxolol—glaucoma	0.000612	0.0016	CcSEcCtD
Norethindrone—Dizziness—Apraclonidine—glaucoma	0.000609	0.00159	CcSEcCtD
Norethindrone—Urticaria—Dorzolamide—glaucoma	0.0006	0.00157	CcSEcCtD
Norethindrone—Abdominal pain—Dorzolamide—glaucoma	0.000597	0.00156	CcSEcCtD
Norethindrone—Tension—Betaxolol—glaucoma	0.000597	0.00156	CcSEcCtD
Norethindrone—Abdominal pain—Travoprost—glaucoma	0.000595	0.00155	CcSEcCtD
Norethindrone—Asthenia—Acetazolamide—glaucoma	0.000591	0.00154	CcSEcCtD
Norethindrone—Dizziness—Bimatoprost—glaucoma	0.000591	0.00154	CcSEcCtD
Norethindrone—Nervousness—Betaxolol—glaucoma	0.000591	0.00154	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000591	0.00154	CcSEcCtD
Norethindrone—Urticaria—Brinzolamide—glaucoma	0.00059	0.00154	CcSEcCtD
Norethindrone—Vomiting—Apraclonidine—glaucoma	0.000586	0.00153	CcSEcCtD
Norethindrone—Gastrointestinal pain—Pilocarpine—glaucoma	0.000584	0.00152	CcSEcCtD
Norethindrone—Hypersensitivity—Brimonidine—glaucoma	0.000583	0.00152	CcSEcCtD
Norethindrone—Dermatitis—Apraclonidine—glaucoma	0.000581	0.00151	CcSEcCtD
Norethindrone—Headache—Apraclonidine—glaucoma	0.000577	0.00151	CcSEcCtD
Norethindrone—Oedema—Clonidine—glaucoma	0.00057	0.00149	CcSEcCtD
Norethindrone—Asthenia—Brimonidine—glaucoma	0.000568	0.00148	CcSEcCtD
Norethindrone—Abdominal pain—Pilocarpine—glaucoma	0.000564	0.00147	CcSEcCtD
Norethindrone—Rash—Bimatoprost—glaucoma	0.000563	0.00147	CcSEcCtD
Norethindrone—Dermatitis—Bimatoprost—glaucoma	0.000563	0.00147	CcSEcCtD
Norethindrone—Connective tissue disorder—Timolol—glaucoma	0.000561	0.00146	CcSEcCtD
Norethindrone—Pruritus—Brimonidine—glaucoma	0.00056	0.00146	CcSEcCtD
Norethindrone—Headache—Bimatoprost—glaucoma	0.00056	0.00146	CcSEcCtD
Norethindrone—Hypersensitivity—Dorzolamide—glaucoma	0.000557	0.00145	CcSEcCtD
Norethindrone—Hypersensitivity—Travoprost—glaucoma	0.000554	0.00145	CcSEcCtD
Norethindrone—Skin disorder—Clonidine—glaucoma	0.000554	0.00145	CcSEcCtD
Norethindrone—Nausea—Apraclonidine—glaucoma	0.000547	0.00143	CcSEcCtD
Norethindrone—Hypersensitivity—Brinzolamide—glaucoma	0.000547	0.00143	CcSEcCtD
Norethindrone—Dizziness—Acetazolamide—glaucoma	0.000545	0.00142	CcSEcCtD
Norethindrone—Asthenia—Dorzolamide—glaucoma	0.000542	0.00141	CcSEcCtD
Norethindrone—Asthenia—Travoprost—glaucoma	0.00054	0.00141	CcSEcCtD
Norethindrone—Pruritus—Dorzolamide—glaucoma	0.000535	0.00139	CcSEcCtD
Norethindrone—Asthenia—Brinzolamide—glaucoma	0.000533	0.00139	CcSEcCtD
Norethindrone—Pruritus—Travoprost—glaucoma	0.000532	0.00139	CcSEcCtD
Norethindrone—Nausea—Bimatoprost—glaucoma	0.000531	0.00138	CcSEcCtD
Norethindrone—Hypersensitivity—Pilocarpine—glaucoma	0.000526	0.00137	CcSEcCtD
Norethindrone—Pruritus—Brinzolamide—glaucoma	0.000526	0.00137	CcSEcCtD
Norethindrone—Vomiting—Acetazolamide—glaucoma	0.000524	0.00137	CcSEcCtD
Norethindrone—Dizziness—Brimonidine—glaucoma	0.000523	0.00137	CcSEcCtD
Norethindrone—Headache—Acetazolamide—glaucoma	0.000516	0.00135	CcSEcCtD
Norethindrone—Insomnia—Clonidine—glaucoma	0.000516	0.00135	CcSEcCtD
Norethindrone—Immune system disorder—Timolol—glaucoma	0.000516	0.00135	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000514	0.00134	CcSEcCtD
Norethindrone—Asthenia—Pilocarpine—glaucoma	0.000512	0.00134	CcSEcCtD
Norethindrone—Hydrocortisone—NR3C1—glaucoma	0.000512	0.102	CrCbGaD
Norethindrone—Somnolence—Clonidine—glaucoma	0.000507	0.00132	CcSEcCtD
Norethindrone—Pruritus—Pilocarpine—glaucoma	0.000505	0.00132	CcSEcCtD
Norethindrone—Alopecia—Timolol—glaucoma	0.000504	0.00132	CcSEcCtD
Norethindrone—Mental disorder—Timolol—glaucoma	0.0005	0.0013	CcSEcCtD
Norethindrone—Dizziness—Dorzolamide—glaucoma	0.0005	0.0013	CcSEcCtD
Norethindrone—Rash—Brimonidine—glaucoma	0.000499	0.0013	CcSEcCtD
Norethindrone—Dermatitis—Brimonidine—glaucoma	0.000498	0.0013	CcSEcCtD
Norethindrone—Dizziness—Travoprost—glaucoma	0.000498	0.0013	CcSEcCtD
Norethindrone—Oedema—Betaxolol—glaucoma	0.000496	0.0013	CcSEcCtD
Norethindrone—Headache—Brimonidine—glaucoma	0.000496	0.00129	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Clonidine—glaucoma	0.000492	0.00128	CcSEcCtD
Norethindrone—Fatigue—Clonidine—glaucoma	0.000492	0.00128	CcSEcCtD
Norethindrone—Dizziness—Brinzolamide—glaucoma	0.000491	0.00128	CcSEcCtD
Norethindrone—Nausea—Acetazolamide—glaucoma	0.00049	0.00128	CcSEcCtD
Norethindrone—Tension—Timolol—glaucoma	0.000488	0.00127	CcSEcCtD
Norethindrone—Nervousness—Timolol—glaucoma	0.000483	0.00126	CcSEcCtD
Norethindrone—Skin disorder—Betaxolol—glaucoma	0.000482	0.00126	CcSEcCtD
Norethindrone—Vomiting—Dorzolamide—glaucoma	0.00048	0.00125	CcSEcCtD
Norethindrone—Rash—Dorzolamide—glaucoma	0.000476	0.00124	CcSEcCtD
Norethindrone—Dermatitis—Dorzolamide—glaucoma	0.000476	0.00124	CcSEcCtD
Norethindrone—Rash—Travoprost—glaucoma	0.000474	0.00124	CcSEcCtD
Norethindrone—Dermatitis—Travoprost—glaucoma	0.000474	0.00124	CcSEcCtD
Norethindrone—Headache—Dorzolamide—glaucoma	0.000473	0.00124	CcSEcCtD
Norethindrone—Vomiting—Brinzolamide—glaucoma	0.000472	0.00123	CcSEcCtD
Norethindrone—Dizziness—Pilocarpine—glaucoma	0.000472	0.00123	CcSEcCtD
Norethindrone—Headache—Travoprost—glaucoma	0.000471	0.00123	CcSEcCtD
Norethindrone—Nausea—Brimonidine—glaucoma	0.00047	0.00123	CcSEcCtD
Norethindrone—Rash—Brinzolamide—glaucoma	0.000468	0.00122	CcSEcCtD
Norethindrone—Dermatitis—Brinzolamide—glaucoma	0.000468	0.00122	CcSEcCtD
Norethindrone—Gastrointestinal pain—Clonidine—glaucoma	0.000466	0.00122	CcSEcCtD
Norethindrone—Headache—Brinzolamide—glaucoma	0.000465	0.00121	CcSEcCtD
Norethindrone—Vomiting—Pilocarpine—glaucoma	0.000454	0.00118	CcSEcCtD
Norethindrone—Urticaria—Clonidine—glaucoma	0.000453	0.00118	CcSEcCtD
Norethindrone—Abdominal pain—Clonidine—glaucoma	0.000451	0.00118	CcSEcCtD
Norethindrone—Rash—Pilocarpine—glaucoma	0.00045	0.00117	CcSEcCtD
Norethindrone—Dermatitis—Pilocarpine—glaucoma	0.00045	0.00117	CcSEcCtD
Norethindrone—Insomnia—Betaxolol—glaucoma	0.000449	0.00117	CcSEcCtD
Norethindrone—Nausea—Dorzolamide—glaucoma	0.000449	0.00117	CcSEcCtD
Norethindrone—Headache—Pilocarpine—glaucoma	0.000447	0.00117	CcSEcCtD
Norethindrone—Nausea—Travoprost—glaucoma	0.000447	0.00117	CcSEcCtD
Norethindrone—Nausea—Brinzolamide—glaucoma	0.000441	0.00115	CcSEcCtD
Norethindrone—Dyspepsia—Betaxolol—glaucoma	0.000437	0.00114	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000429	0.00112	CcSEcCtD
Norethindrone—Fatigue—Betaxolol—glaucoma	0.000428	0.00112	CcSEcCtD
Norethindrone—Nausea—Pilocarpine—glaucoma	0.000424	0.00111	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00042	0.0011	CcSEcCtD
Norethindrone—Hypersensitivity—Clonidine—glaucoma	0.00042	0.0011	CcSEcCtD
Norethindrone—Progesterone—NR3C1—glaucoma	0.000417	0.0828	CrCbGaD
Norethindrone—Asthenia—Clonidine—glaucoma	0.000409	0.00107	CcSEcCtD
Norethindrone—Anaphylactic shock—Timolol—glaucoma	0.000406	0.00106	CcSEcCtD
Norethindrone—Oedema—Timolol—glaucoma	0.000406	0.00106	CcSEcCtD
Norethindrone—Pruritus—Clonidine—glaucoma	0.000403	0.00105	CcSEcCtD
Norethindrone—Urticaria—Betaxolol—glaucoma	0.000394	0.00103	CcSEcCtD
Norethindrone—Skin disorder—Timolol—glaucoma	0.000394	0.00103	CcSEcCtD
Norethindrone—Dizziness—Clonidine—glaucoma	0.000377	0.000984	CcSEcCtD
Norethindrone—Insomnia—Timolol—glaucoma	0.000367	0.000957	CcSEcCtD
Norethindrone—Hypersensitivity—Betaxolol—glaucoma	0.000366	0.000954	CcSEcCtD
Norethindrone—Vomiting—Clonidine—glaucoma	0.000363	0.000946	CcSEcCtD
Norethindrone—Somnolence—Timolol—glaucoma	0.000361	0.000941	CcSEcCtD
Norethindrone—Rash—Clonidine—glaucoma	0.000359	0.000938	CcSEcCtD
Norethindrone—Dermatitis—Clonidine—glaucoma	0.000359	0.000937	CcSEcCtD
Norethindrone—Headache—Clonidine—glaucoma	0.000357	0.000932	CcSEcCtD
Norethindrone—Dyspepsia—Timolol—glaucoma	0.000357	0.000931	CcSEcCtD
Norethindrone—Asthenia—Betaxolol—glaucoma	0.000356	0.000929	CcSEcCtD
Norethindrone—Pruritus—Betaxolol—glaucoma	0.000351	0.000916	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Timolol—glaucoma	0.00035	0.000914	CcSEcCtD
Norethindrone—Fatigue—Timolol—glaucoma	0.00035	0.000912	CcSEcCtD
Norethindrone—Nausea—Clonidine—glaucoma	0.000339	0.000884	CcSEcCtD
Norethindrone—Gastrointestinal pain—Timolol—glaucoma	0.000332	0.000865	CcSEcCtD
Norethindrone—Dizziness—Betaxolol—glaucoma	0.000328	0.000857	CcSEcCtD
Norethindrone—Urticaria—Timolol—glaucoma	0.000322	0.000841	CcSEcCtD
Norethindrone—Abdominal pain—Timolol—glaucoma	0.000321	0.000836	CcSEcCtD
Norethindrone—Vomiting—Betaxolol—glaucoma	0.000316	0.000824	CcSEcCtD
Norethindrone—Rash—Betaxolol—glaucoma	0.000313	0.000817	CcSEcCtD
Norethindrone—Dermatitis—Betaxolol—glaucoma	0.000313	0.000816	CcSEcCtD
Norethindrone—Headache—Betaxolol—glaucoma	0.000311	0.000811	CcSEcCtD
Norethindrone—Hypersensitivity—Timolol—glaucoma	0.000299	0.00078	CcSEcCtD
Norethindrone—Nausea—Betaxolol—glaucoma	0.000295	0.000769	CcSEcCtD
Norethindrone—Asthenia—Timolol—glaucoma	0.000291	0.000759	CcSEcCtD
Norethindrone—Pruritus—Timolol—glaucoma	0.000287	0.000749	CcSEcCtD
Norethindrone—Dizziness—Timolol—glaucoma	0.000268	0.0007	CcSEcCtD
Norethindrone—Vomiting—Timolol—glaucoma	0.000258	0.000673	CcSEcCtD
Norethindrone—Rash—Timolol—glaucoma	0.000256	0.000667	CcSEcCtD
Norethindrone—Dermatitis—Timolol—glaucoma	0.000255	0.000667	CcSEcCtD
Norethindrone—Headache—Timolol—glaucoma	0.000254	0.000663	CcSEcCtD
Norethindrone—Nausea—Timolol—glaucoma	0.000241	0.000629	CcSEcCtD
Norethindrone—PGR—Validated nuclear estrogen receptor alpha network—C3—glaucoma	9.68e-05	0.0119	CbGpPWpGaD
Norethindrone—ALB—Lipoprotein metabolism—ABCA1—glaucoma	8.9e-05	0.0109	CbGpPWpGaD
Norethindrone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.21e-05	0.0101	CbGpPWpGaD
Norethindrone—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	8.21e-05	0.0101	CbGpPWpGaD
Norethindrone—CYP3A7—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.11e-05	0.00994	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	7.76e-05	0.00951	CbGpPWpGaD
Norethindrone—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	7.23e-05	0.00886	CbGpPWpGaD
Norethindrone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.06e-05	0.00865	CbGpPWpGaD
Norethindrone—CYP3A7—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.66e-05	0.00816	CbGpPWpGaD
Norethindrone—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	6.64e-05	0.00814	CbGpPWpGaD
Norethindrone—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	6.39e-05	0.00784	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—TXN—glaucoma	6.09e-05	0.00747	CbGpPWpGaD
Norethindrone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.94e-05	0.00728	CbGpPWpGaD
Norethindrone—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	5.92e-05	0.00725	CbGpPWpGaD
Norethindrone—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.86e-05	0.00718	CbGpPWpGaD
Norethindrone—ALB—Lipoprotein metabolism—APOE—glaucoma	5.86e-05	0.00718	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	5.82e-05	0.00714	CbGpPWpGaD
Norethindrone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	5.78e-05	0.00709	CbGpPWpGaD
Norethindrone—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	5.4e-05	0.00662	CbGpPWpGaD
Norethindrone—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	5.31e-05	0.00651	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	5.19e-05	0.00636	CbGpPWpGaD
Norethindrone—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	4.85e-05	0.00594	CbGpPWpGaD
Norethindrone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.81e-05	0.0059	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—TGFB2—glaucoma	4.78e-05	0.00586	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—ABCA1—glaucoma	4.74e-05	0.00581	CbGpPWpGaD
Norethindrone—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	4.67e-05	0.00573	CbGpPWpGaD
Norethindrone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.59e-05	0.00563	CbGpPWpGaD
Norethindrone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	4.56e-05	0.00559	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	4.55e-05	0.00558	CbGpPWpGaD
Norethindrone—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.53e-05	0.00555	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—GSTT1—glaucoma	4.44e-05	0.00544	CbGpPWpGaD
Norethindrone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	4.35e-05	0.00533	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—SOD1—glaucoma	4.22e-05	0.00518	CbGpPWpGaD
Norethindrone—PGR—Signaling by ERBB4—BAD—glaucoma	4.2e-05	0.00515	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	4.11e-05	0.00504	CbGpPWpGaD
Norethindrone—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	3.89e-05	0.00477	CbGpPWpGaD
Norethindrone—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	3.86e-05	0.00473	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—APOE—glaucoma	3.83e-05	0.00469	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	3.76e-05	0.00461	CbGpPWpGaD
Norethindrone—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.72e-05	0.00456	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—SOD1—glaucoma	3.62e-05	0.00444	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—CYP1B1—glaucoma	3.54e-05	0.00434	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	3.52e-05	0.00431	CbGpPWpGaD
Norethindrone—CYP3A7—Metapathway biotransformation—CYP1B1—glaucoma	3.49e-05	0.00428	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—LRP12—glaucoma	3.46e-05	0.00424	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	3.45e-05	0.00423	CbGpPWpGaD
Norethindrone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	3.41e-05	0.00418	CbGpPWpGaD
Norethindrone—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	3.36e-05	0.00412	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—SOD1—glaucoma	3.35e-05	0.00411	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—MTHFR—glaucoma	3.35e-05	0.0041	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—GSTT1—glaucoma	3.21e-05	0.00393	CbGpPWpGaD
Norethindrone—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	3.12e-05	0.00382	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CA5A—glaucoma	3.11e-05	0.00381	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NARFL—glaucoma	3.11e-05	0.00381	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	3.08e-05	0.00378	CbGpPWpGaD
Norethindrone—PGR—Signaling by ERBB4—CDKN1B—glaucoma	2.93e-05	0.00359	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—IL1A—glaucoma	2.89e-05	0.00354	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—GSTM1—glaucoma	2.83e-05	0.00347	CbGpPWpGaD
Norethindrone—CYP3A7—Metapathway biotransformation—GSTM1—glaucoma	2.79e-05	0.00342	CbGpPWpGaD
Norethindrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.76e-05	0.00338	CbGpPWpGaD
Norethindrone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.72e-05	0.00334	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	2.66e-05	0.00326	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—FAS—glaucoma	2.58e-05	0.00316	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—CYP1B1—glaucoma	2.56e-05	0.00313	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—C3—glaucoma	2.54e-05	0.00311	CbGpPWpGaD
Norethindrone—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	2.52e-05	0.00309	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—FN1—glaucoma	2.52e-05	0.00309	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—GSTT1—glaucoma	2.48e-05	0.00304	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—OPN4—glaucoma	2.4e-05	0.00294	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	2.4e-05	0.00294	CbGpPWpGaD
Norethindrone—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	2.39e-05	0.00293	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	2.39e-05	0.00293	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.38e-05	0.00291	CbGpPWpGaD
Norethindrone—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	2.28e-05	0.0028	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CA5A—glaucoma	2.25e-05	0.00276	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NARFL—glaucoma	2.25e-05	0.00276	CbGpPWpGaD
Norethindrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	2.25e-05	0.00276	CbGpPWpGaD
Norethindrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.24e-05	0.00274	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HEYL—glaucoma	2.23e-05	0.00274	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	2.18e-05	0.00267	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PTGFR—glaucoma	2.16e-05	0.00265	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	2.12e-05	0.0026	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—NR3C1—glaucoma	2.1e-05	0.00257	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.08e-05	0.00255	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.06e-05	0.00252	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—GSTM1—glaucoma	2.04e-05	0.00251	CbGpPWpGaD
Norethindrone—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	2.02e-05	0.00247	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—CYP1B1—glaucoma	1.98e-05	0.00242	CbGpPWpGaD
Norethindrone—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	1.95e-05	0.00239	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NARFL—glaucoma	1.94e-05	0.00237	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CA5A—glaucoma	1.94e-05	0.00237	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.85e-05	0.00226	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—TNF—glaucoma	1.77e-05	0.00217	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NARFL—glaucoma	1.74e-05	0.00213	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CA5A—glaucoma	1.74e-05	0.00213	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NARFL—glaucoma	1.7e-05	0.00208	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CA5A—glaucoma	1.7e-05	0.00208	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	1.7e-05	0.00208	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RPTOR—glaucoma	1.69e-05	0.00207	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NCK2—glaucoma	1.64e-05	0.00201	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	1.62e-05	0.00199	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	1.61e-05	0.00197	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.58e-05	0.00194	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—GSTM1—glaucoma	1.58e-05	0.00194	CbGpPWpGaD
Norethindrone—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	1.56e-05	0.00191	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CA1—glaucoma	1.52e-05	0.00186	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.5e-05	0.00183	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.49e-05	0.00183	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.49e-05	0.00182	CbGpPWpGaD
Norethindrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	1.47e-05	0.00181	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CTSA—glaucoma	1.47e-05	0.0018	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—VEGFA—glaucoma	1.44e-05	0.00177	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—TNF—glaucoma	1.44e-05	0.00177	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HDAC9—glaucoma	1.39e-05	0.00171	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CA2—glaucoma	1.39e-05	0.0017	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.39e-05	0.0017	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	1.37e-05	0.00168	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.28e-05	0.00156	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.27e-05	0.00156	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—TP53—glaucoma	1.27e-05	0.00156	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.19e-05	0.00146	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.17e-05	0.00144	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.16e-05	0.00142	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—CDKN2B—glaucoma	1.15e-05	0.00141	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—TNF—glaucoma	1.15e-05	0.0014	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	1.12e-05	0.00137	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CA1—glaucoma	1.1e-05	0.00135	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—TNF—glaucoma	1.09e-05	0.00134	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB2—glaucoma	1.09e-05	0.00134	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SMO—glaucoma	1.09e-05	0.00134	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.09e-05	0.00133	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CTSA—glaucoma	1.06e-05	0.0013	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA5A—glaucoma	1.05e-05	0.00128	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NARFL—glaucoma	1.05e-05	0.00128	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.02e-05	0.00125	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—NR3C1—glaucoma	1.01e-05	0.00124	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CA2—glaucoma	1e-05	0.00123	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NTRK2—glaucoma	9.97e-06	0.00122	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—TXN—glaucoma	9.79e-06	0.0012	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—GSTM1—glaucoma	9.5e-06	0.00116	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CA1—glaucoma	9.46e-06	0.00116	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	9.37e-06	0.00115	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CTSA—glaucoma	9.16e-06	0.00112	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CA2—glaucoma	8.65e-06	0.00106	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NGFR—glaucoma	8.55e-06	0.00105	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CA1—glaucoma	8.49e-06	0.00104	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.46e-06	0.00104	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.46e-06	0.00104	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CA1—glaucoma	8.29e-06	0.00102	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SOD1—glaucoma	8.28e-06	0.00101	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CTSA—glaucoma	8.22e-06	0.00101	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NTRK1—glaucoma	8.13e-06	0.000996	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CTSA—glaucoma	8.03e-06	0.000984	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8e-06	0.00098	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CA2—glaucoma	7.77e-06	0.000952	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTT1—glaucoma	7.59e-06	0.000931	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.59e-06	0.00093	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.59e-06	0.00093	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CA2—glaucoma	7.58e-06	0.000929	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.57e-06	0.000928	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN2B—glaucoma	7.49e-06	0.000918	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EDN1—glaucoma	7.19e-06	0.000881	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TXN—glaucoma	7.08e-06	0.000867	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NGF—glaucoma	6.6e-06	0.000809	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	6.4e-06	0.000784	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MMP1—glaucoma	6.31e-06	0.000774	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.3e-06	0.000772	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—C3—glaucoma	6.28e-06	0.000769	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TXN—glaucoma	6.1e-06	0.000747	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—CAV1—glaucoma	6.05e-06	0.000742	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP1B1—glaucoma	6.05e-06	0.000741	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCA1—glaucoma	6.05e-06	0.000741	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APOE—glaucoma	5.84e-06	0.000716	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CAV1—glaucoma	5.79e-06	0.00071	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—FN1—glaucoma	5.76e-06	0.000706	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.56e-06	0.000682	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FN1—glaucoma	5.51e-06	0.000675	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.51e-06	0.000675	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTT1—glaucoma	5.49e-06	0.000673	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TXN—glaucoma	5.47e-06	0.000671	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—BAD—glaucoma	5.45e-06	0.000667	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.4e-06	0.000662	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TXN—glaucoma	5.34e-06	0.000655	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA1—glaucoma	5.11e-06	0.000626	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.99e-06	0.000612	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.95e-06	0.000606	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CTSA—glaucoma	4.95e-06	0.000606	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTM1—glaucoma	4.84e-06	0.000593	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.76e-06	0.000583	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTT1—glaucoma	4.73e-06	0.000579	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA2—glaucoma	4.67e-06	0.000572	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NOS3—glaucoma	4.58e-06	0.000561	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NOS3—glaucoma	4.38e-06	0.000537	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCA1—glaucoma	4.37e-06	0.000536	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP1B1—glaucoma	4.37e-06	0.000536	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—glaucoma	4.27e-06	0.000524	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTT1—glaucoma	4.24e-06	0.00052	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTT1—glaucoma	4.14e-06	0.000508	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOE—glaucoma	3.98e-06	0.000488	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CAV1—glaucoma	3.94e-06	0.000483	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.81e-06	0.000467	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1B—glaucoma	3.79e-06	0.000465	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP1B1—glaucoma	3.77e-06	0.000462	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCA1—glaucoma	3.77e-06	0.000462	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—glaucoma	3.51e-06	0.000431	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—glaucoma	3.5e-06	0.000428	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.42e-06	0.000419	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCA1—glaucoma	3.38e-06	0.000414	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP1B1—glaucoma	3.38e-06	0.000414	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP1B1—glaucoma	3.3e-06	0.000404	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ABCA1—glaucoma	3.3e-06	0.000404	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—glaucoma	3.3e-06	0.000404	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TXN—glaucoma	3.29e-06	0.000403	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—glaucoma	3.15e-06	0.000387	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—glaucoma	3.09e-06	0.000379	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—glaucoma	3.01e-06	0.000369	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NOS3—glaucoma	2.98e-06	0.000365	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOE—glaucoma	2.88e-06	0.000353	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CAV1—glaucoma	2.85e-06	0.000349	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—glaucoma	2.73e-06	0.000334	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—glaucoma	2.7e-06	0.000331	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—glaucoma	2.66e-06	0.000326	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—glaucoma	2.64e-06	0.000323	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTT1—glaucoma	2.55e-06	0.000313	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—glaucoma	2.49e-06	0.000305	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOE—glaucoma	2.48e-06	0.000304	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CAV1—glaucoma	2.45e-06	0.000301	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—glaucoma	2.39e-06	0.000293	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—glaucoma	2.38e-06	0.000292	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—glaucoma	2.33e-06	0.000286	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOE—glaucoma	2.22e-06	0.000273	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CAV1—glaucoma	2.2e-06	0.00027	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOE—glaucoma	2.17e-06	0.000266	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NOS3—glaucoma	2.15e-06	0.000264	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CAV1—glaucoma	2.15e-06	0.000264	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCA1—glaucoma	2.03e-06	0.000249	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP1B1—glaucoma	2.03e-06	0.000249	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—glaucoma	1.97e-06	0.000242	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NOS3—glaucoma	1.86e-06	0.000227	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—glaucoma	1.7e-06	0.000208	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NOS3—glaucoma	1.67e-06	0.000204	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NOS3—glaucoma	1.63e-06	0.000199	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—glaucoma	1.63e-06	0.000199	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—glaucoma	1.52e-06	0.000187	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—glaucoma	1.49e-06	0.000182	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—glaucoma	1.44e-06	0.000176	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOE—glaucoma	1.34e-06	0.000164	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CAV1—glaucoma	1.32e-06	0.000162	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NOS3—glaucoma	1e-06	0.000123	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—glaucoma	9.16e-07	0.000112	CbGpPWpGaD
